Vanda Pharmaceuticals Inc (VNDA) Stock Analysis

Vanda Pharmaceuticals Inc (VNDA) is a publicly traded company in the HEALTHCARE sector. It trades at $6.13, carries a market capitalization of $382.76M. This page summarizes the public market data, fundamentals, and frequently asked questions for VNDA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Vanda Pharmaceuticals Inc currently has a Bearish sentiment score of -0.16.

About Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Washington, D.C., dedicated to developing and commercializing innovative therapies aimed at addressing significant unmet medical needs in various therapeutic areas, including central nervous system disorders and sleep disorders. With a strong commitment to advancing patient care and a robust pipeline, Vanda leverages its scientific expertise to deliver transformative solutions to patients and healthcare providers alike...

GNG Research Analysis

GNG Research scores Vanda Pharmaceuticals Inc (VNDA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VNDA.

Frequently Asked Questions

Does VNDA pay dividends?

Vanda Pharmaceuticals Inc (VNDA) does not currently pay a regular dividend.

What is VNDA's market cap?

Vanda Pharmaceuticals Inc (VNDA) has a market capitalization of $382.76M with a current stock price of $6.13.